FEMOX: Fetal Extracellular vesicle based Monitoring of Oxygenation
FEMOx enables rapid, non-invasive detection of fetal hypoxia using a microfluidic-based point of care device to capture fetal and placental extracellular vesicles and evaluate the mRNA contents to predict risk of fetal hypoxia. This will improve maternal-fetal safety and decision-making and supports clinical translation.